- Home
- DSGN vs TDF Comparison
DSGN vs TDF Comparison
Compare DSGN & TDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- TDF
- Stock Information
- Founded
- DSGN 2017
- TDF 1994
- Country
- DSGN United States
- TDF Singapore
- Employees
- DSGN N/A
- TDF N/A
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- TDF Finance/Investors Services
- Sector
- DSGN Health Care
- TDF Finance
- Exchange
- DSGN Nasdaq
- TDF Nasdaq
- Market Cap
- DSGN 264.4M
- TDF 197.2M
- IPO Year
- DSGN 2021
- TDF N/A
- Fundamental
- Price
- DSGN $4.67
- TDF $7.72
- Analyst Decision
- DSGN Hold
- TDF
- Analyst Count
- DSGN 3
- TDF 0
- Target Price
- DSGN $7.00
- TDF N/A
- AVG Volume (30 Days)
- DSGN 181.2K
- TDF 79.2K
- Earning Date
- DSGN 08-05-2024
- TDF 01-01-0001
- Dividend Yield
- DSGN N/A
- TDF N/A
- EPS Growth
- DSGN N/A
- TDF N/A
- EPS
- DSGN N/A
- TDF N/A
- Revenue
- DSGN N/A
- TDF N/A
- Revenue This Year
- DSGN N/A
- TDF N/A
- Revenue Next Year
- DSGN N/A
- TDF N/A
- P/E Ratio
- DSGN N/A
- TDF N/A
- Revenue Growth
- DSGN N/A
- TDF N/A
- 52 Week Low
- DSGN $1.96
- TDF $7.15
- 52 Week High
- DSGN $5.48
- TDF $10.62
- Technical
- Relative Strength Index (RSI)
- DSGN 50.29
- TDF 43.26
- Support Level
- DSGN $4.52
- TDF $7.72
- Resistance Level
- DSGN $4.87
- TDF $7.87
- Average True Range (ATR)
- DSGN 0.36
- TDF 0.10
- MACD
- DSGN -0.04
- TDF -0.00
- Stochastic Oscillator
- DSGN 19.80
- TDF 17.31
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About TDF Templeton Dragon Fund Inc.
Templeton Dragon Fund Inc is a closed-end management investment company. The fund seeks long-term capital appreciation by investing majority of its total assets in equity securities of China companies. It invests in various sectors such as gas & consumable fuels, auto components, banks, beverages, communications equipment, healthcare equipment & supplies, restaurants & leisure, household durables, and many others.